M. Hann

Molecular Biology · 2001–2013

A researcher in the Science corpus: 4 papers; trusts 8 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom M. Hann trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Matthew Paul Gleeson
  2. Jürgen Bajorath
  3. Paul D. Leeson
  4. Timothy J. Ritchie
  5. A. Hopkins
  6. Michael J. Waring

Who trusts M. Hann overall

  1. Kalyan Immadisetty
  2. A. Hopkins
  3. Michelle Arkin
  4. D. Erlanson
  5. W. Patrick Walters
  6. Paul D. Leeson
  7. D. Rees
  8. Laura M. Geffert
  9. Philip J. Hajduk
  10. Yu Chen

Papers from M. Hann's perspective

Ordered by how strongly the researchers M. Hann trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery (Journal of chemical information and computer sciences)
  2. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
  3. The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? (Drug Discovery Today)
  4. Integration of virtual and high-throughput screening
  5. Escape from flatland: increasing saturation as an approach to improving clinical success.
  6. Ligand efficiency: a useful metric for lead selection. (Drug Discovery Today)
  7. The influence of drug-like concepts on decision-making in medicinal chemistry (Nature reviews. Drug discovery)
  8. Generation of a set of simple, interpretable ADMET rules of thumb. (Journal of Medicinal Chemistry)
  9. Can the pharmaceutical industry reduce attrition rates?
  10. Molecular properties that influence the oral bioavailability of drug candidates. (Journal of Medicinal Chemistry)

Their papers